Real-time enrollment status for this leptomeningeal metastasis clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 6:27 AM UTC
| NCT Number | NCT06500481 |
| Recruiting Status | Recruiting |
| Condition | Leptomeningeal Metastasis |
| Phase | PHASE3 |
| Target Enrollment | 115 participants |
| Active Locations | 58 sites in the US |
| Sponsor | NRG Oncology |
| Last Updated on CT.gov | August 17, 2026 (2 weeks ago) |
As of August 31, 2026: Clinical trial NCT06500481 is currently recruiting participants. This phase3 study for leptomeningeal metastasis is actively seeking new participants at 58 locations across the United States. The study is sponsored by NRG Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06500481 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 58 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06500481 was last updated 2 weeks ago (August 17, 2026). HelloStudys verifies this status automatically.